0001567619-21-008605.txt : 20210426 0001567619-21-008605.hdr.sgml : 20210426 20210426180540 ACCESSION NUMBER: 0001567619-21-008605 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210416 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Caroline C CENTRAL INDEX KEY: 0001858103 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 21855291 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 3 1 doc1.xml FORM 3 X0206 3 2021-04-16 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001858103 Williams Caroline C 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 0 0 1 0 Common Stock 1272972 D Common Stock 2471479 I The Starwood Trust Common Stock 1272972 I Caroline Constance Williams 2021 Irrevocable Trust Stock Option (Right to Buy) 2023-04-16 Common Stock 1275731 I The Starwood Trust Received in exchange for shares of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") in connection with the merger of the Former Entity with a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share (after giving effect to a reverse stock split on April 19, 2021). The reporting person is a trustee of the trust and a beneficiary of the trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. The reporting person is a beneficiary of the trust but not a trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. These options are fully vested and exercisable. Received in the Merger in exchange for a stock option to acquire shares of the Former Entity at $1.00 per share. /s/ Caroline C. Williams 2021-04-26